መነሻ › ፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ › Texas
በTexas ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለፎካል ሴግመንታል ግሎሜሩሎስክሌሮሲስ የሚደረጉ 5 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTexas ውስጥ ያሉ ከተሞች
Official study text (English)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #5, Arlington
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
- The Healing Kidneys Institute, Conroe
- Advanced Dallas Hospital and Clinics, Dallas
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ12 ሜይ 2026 · NCT05003986ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።